Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.

about

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.

Item

http://www.wikidata.org/entity/Q47548487

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Immunomodulatory Therapy of Vi ...... ncy Virus-Coinfected Patients.

@en

Immunomodulatory Therapy of Vi ...... ncy Virus-Coinfected Patients.

@nl

type

Item

label

Immunomodulatory Therapy of Vi ...... ncy Virus-Coinfected Patients.

@en

Immunomodulatory Therapy of Vi ...... ncy Virus-Coinfected Patients.

@nl

prefLabel

Immunomodulatory Therapy of Vi ...... ncy Virus-Coinfected Patients.

@en

Immunomodulatory Therapy of Vi ...... ncy Virus-Coinfected Patients.

@nl

P1476

Immunomodulatory Therapy of Vi ...... ency Virus-Coinfected Patients

@en

P2093

Guido Vanham

http://www.w3.org/2001/XMLSchema#string

Johan van Griensven

http://www.w3.org/2001/XMLSchema#string

Luc Kestens

http://www.w3.org/2001/XMLSchema#string

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Visceral Leishmaniasis and HIV coinfection in East Africa

IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani

Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection.

Immunotherapy for tuberculosis: future prospects

Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?

B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections

Regulation of immunity during visceral Leishmania infection

Perspectives for immunotherapy: which applications might achieve an HIV functional cure?

Hepatic interleukin-7 expression regulates T cell responses

P304

1943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.01943

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wim Adriaensen

Paul M Kaye

Thomas P C Dorlo

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29375567

http://www.w3.org/2001/XMLSchema#string

P932

5770372

http://www.w3.org/2001/XMLSchema#string